A BRCA2 protein-truncating pathogenic variant (p.Asp946Ilefs*14) was detected in an unselected pancreatic cancer patient, accounting for 0.7% (1/150) prevalence in the cohort. Here, BRCA2 is linked to pancreatic neoplasm.